SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2024 financial results and provided a corporate update.

Medical experts reveal the surprising daily behaviors that harm kidney health, from common drinking habits to unexpected ...

The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...

Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers Halle (Saale) / Munich, Germany, February 19, 2025 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150 ...

Urine is the result of a fascinating and complex system, of which the kidneys are the star, that evolved to keep our internal ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Meet mild, reversible acute kidney injury (AKI) -- a sudden loss of kidney function that can go away within 24 hours or, if unchecked, can lead to chronic kidney failure, dialysis or transplant! It ...

A new study from Karolinska Institutet explores the connection between inflammatory bowel disease (IBD) and chronic kidney ...

Summer days spent swimming in lakes are a cherished pastime for many of us. But for one 77-year-old man, a refreshing dip ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Living kidney donors with discordant kidney function measures had lower eGFR after donation and a higher risk for eGFR counts below 45 mL/min/1.73 m2, researchers found. “Living donor kidney ...